4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis

European Journal of Pharmacology

Volumn 660, Issue 2-3, 2011, Pages 445-453

  De Almeida, Ana Carolina ^a   Marques, Otávio Cabral ^b   Arslanian, Christina ^b   Condino Neto, Antonio ^b   Ximenes, Valdecir F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apocynin; Myeloperoxidase; NADPH oxidase; Neutrophil; Phagocytosis; TNF

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIINFLAMMATORY AGENT; APOCYNIN; F APOCYNIN; FLUORINE; MYELOPEROXIDASE; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE; CHLORINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; LIPOPHILICITY; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ACETOPHENONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CANDIDA ALBICANS; CELL MEMBRANE; GUAIACOL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPOCHLOROUS ACID; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; OXIDANTS; PEROXIDASE; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956158020     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.03.043     Document Type: Article

References (34)

1. Allen, C.L., Bayraktutan, U., 2008. Differential mechanisms of angiotensin II and PDGFBB on migration and proliferation of coronary artery smooth muscle cells. J. Mol. Cell. Cardiol. 45, 198-208.
2. Barbieri, S.S., Cavalca, V., Eligini, S., Brambilla, M., Caiani, A., Tremoli, E., Colli, S., 2004. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic. Biol. Med. 37, 156-165.
3. Brochetta, C., Perrotta, M.G., Jeromin, A., Romano, M., Vita, F., Soranzo, M.R., Borelli, V., Roder, J., Zabucchi, G., 2003. Identification and subcellular localization of neuronal calcium sensor-1 (NCS-1) in human neutrophils and HL-60 cells. Inflammation 27, 361-372. (Pubitemid 38021748)
4. Cathcart, M., 2004. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 23-28.
5. Dharmarajah, J., Arthur, J.F., Sobey, C.G., Drummond, G.R., 2010. The anti-platelet effects of apocynin in mice are not mediated by inhibition of NADPH oxidase activity. Naunyn Schmiedebergs Arch Pharmacol 382, 377-384.
6. Engels, F., Renirie, B.F., Hart, B.A., Labadie, R.P., Nijkamp, F.P., 1992. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett. 305, 254-256.
7. Groemping, Y., Rittinger, K., 2005. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem. J. 386, 401-416. (Pubitemid 40445864)
8. Hansson, M., Olsson, I., Nauseef, W.M., 2006. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch. Biochem. Biophys. 445, 214-224.
9. Hasui, M., Hirabayashi, Y., Kobayashi, Y., 1989. Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J. Immunol. Methods 117, 53-58. (Pubitemid 19038718)
10. Heumuller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H.H., Busse, R., Schroder, K., Brandes, R.P., 2008. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51, 211-217. (Pubitemid 351159930)
11. Jantschko, P.G., Furtmuller,W., Zederbauer,M.,Neugschwandtner,K., Lehner, I., Jakopitsch, C., Arnhold, J., Obinger, C., 2005. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design. Biochem. Pharmacol. 69, 1149-1157.
12. Jo, H., Song, H., Mowbray, A., 2006. Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosis. Antioxid. Redox Signal. 8, 1609-1619.
13. Kanegae, M.P., da Fonseca, L.M., Brunetti, I.L., Silva, S.O., Ximenes, V.F., 2007. The reactivity of ortho-methoxi-substituted catechol radicals with sulfhydryl groups: contribution for the comprehension of the mechanism of inhibition of NADPH oxidase by apocynin. Biochem. Pharmacol. 74, 457-464.
14. Klebanoff, S.J., 2005. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77, 598-625.
15. Lafeber, F.P., Beukelman, C.J., van den Worm, E., van Roy, J.L., Vianen, M.E., van Roon, J.A., van Dijk, H., Bijlsma, J.W., 1999. Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 38, 1088-1093. (Pubitemid 29537328)
16. Malle, E., Furtmuller, P.G., Sattler, W., Obinger, C., 2007. Myeloperoxidase: a target for new drug development? Br. J. Pharmacol. 152, 838-854. (Pubitemid 350100486)
17. Mazor, R., Itzhaki, O., Sela, S., Yagil, Y., Cohen-Mazor, M., Yagil, C., Kristal, B., 2010. Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Hypertension 55, 353-362.
18. Montgomery, D., 1991. Design and Analysis of Experiments. JohnWiley & Sons, NewYork.
19. Munzel, T., Afanas'ev, I.B., Kleschyov, A.L., Harrison, D.G., 2002. Detection of superoxide in vascular tissue. Arterioscler. Thromb. Vasc. Biol. 22, 1761-1768.
20. Nauseef, W.M., 2001. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int. J. Hematol. 74, 125-133.
21. Pandey, A., Kour, K., Bani, S., Suri, K.A., Satti, N.K., Sharma, P., Qazi, G.N., 2009. Amelioration of adjuvant induced arthritis by apocynin. Phytother. Res. 23, 1462-1468.
22. Paterniti, I., Galuppo, M., Mazzon, E., Impellizzeri, D., Esposito, E., Bramanti, P., Cuzzocrea, S., 2010. Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion. J. Leukoc. Biol. 88, 993-1003.
23. Poole, S.K., Poole, C.F., 2003. Separation methods for estimating octanol - water partition coefficients. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 797, 3-19.
24. Stefanska, J., Pawliczak, R., 2008. Apocynin: Molecular Aptitudes. Mediators Inflamm 106507.
25. Stolk, J., Hiltermann, T.J., Dijkman, J.H., Verhoeven, A.J., 1994. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxysubstituted catechol. Am. J. Respir. Cell Mol. Biol. 11, 95-102.
26. Sun, G.Y., Horrocks, L.A., Farooqui, A.A., 2007. The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases. J. Neurochem. 103, 1-16. (Pubitemid 47404193)
27. Tang, J.L., Chen, W.P., Xiong, Y., Hu, P.F., Wu, L.D., 2010. The anti-inflammatory effects of apocynin, inhibitor of NADPH oxidase, contrasting hyaluronic acid on articular cartilage during the development of osteoarthritis in a rabbit model. Biomed. Pharmacother.
28. Ushio-Fukai, M., 2009. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signal. 11, 1289-1299.
29. Van den Worm, E., 2001. Investigations on Apocynin, a Potent NADPH Oxidase Inhibitor. Department of Medicinal Chemistry. Utrecht University. Ph.D, Utrecht, p. 130.
30. Van der Veen, B.S., de Winther, M.P., Heeringa, P., 2009. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signal. 11, 2899-2937.
31. + T cells from HIV-1-infected individuals. Proc. Natl. Acad. Sci. U S A 104, 2355-2360.
32. Weinstein, D.A., Kirsner, R.S., 2010. Refractory ulcers: the role of tumor necrosis factor-alpha. J. Am. Acad. Dermatol. 63, 146-154.
33. White-Owen, C., Alexander, J.W., Sramkosky, R.M., Babcock, G.F., 1992. Rapid whole-blood microassay using flow cytometry for measuring neutrophil phagocytosis. J. Clin. Microbiol. 2071-2076.
34. Zhang, Y., Chan, M.M., Andrews,M.C., Mori, T.A., Croft, K.D.,McKenzie, K.U., Schyvens, C.G., Whitworth, J.A., 2005. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am. J. Hypertens. 18, 910-916.